Sun Pharmaceutical Industries Ltd. closed 8.84% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceutical Industries Ltd. closed 7.94% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

The MM-II trial was carried out in partnership with Israel-based Moebius Medical and included 397 patients in the US, Europe, ...

Discover the Sun Pharma Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Systematix Group's Vishal Manchanda anticipates Q4 results for pharma companies to align with previous quarters, with high ...

Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

US market exposure limits Indian pharma's safe-haven appeal amid global volatility and tariff fears, but drugmakers focused on domestic markets can officer investors a potential hedge against uncertai ...

Analysts have advised investors to buy Sun Pharmaceutical Industries Ltd., Hindustan Unilever Ltd. and Castrol India Ltd.

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun Pharma appealed an injunction handed down in New Jersey federal court in ...

Trump Tariffs Impact, Indian Pharma stocks & share price updates: Nifty Pharma index soared over 4% in early trade before settling 2% higher, despite equity indices recording modest losses due to US ...

Buy SBI May Futures in the range of Rs 820–800. Sun Pharmaceutical has seen long liquidation throughout its uptrend, and the ...